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Table 1
Distribution of smoking behaviour (n, %) in mothers of twins born after a sponta-
neous pregnancy or after fertility treatment.
Smoking behaviour
of the mother
Spontaneous
twin pregnancy
Twin pregnancy after
fertility treatment
Never smoked 9235 (64.8%) 3040 (69.7%)
Smoked prior to, but
not during, the twin pregnancy
2742 (19.3%) 862 (19.8%)
Smoked prior to and during
the twin pregnancy
2266 (15.9%) 462 (10.6%)
Note: complete data on mode of conception and smoking were available for 18,607
biological mothers of twins.
a Schneider et al. have indicated that these data are available and will be the
focus of a subsequent Short Communication.
Letters to the Editors / Public Health 123 (2009) 400–402 401from McKeganey are that drug treatment services have been very
successful in recruiting drug users, that methadone has now over-
whelmed the provision of other drug treatment services in Scotland
and that the expansion of methadone services has occurred without
clear evidence of the beneﬁts of that provision. Whilst there remains
no accurate data on the number of drug users prescribedmethadone
in Scotland, research undertaken by the Scottish Executive in 20055
estimates that the number of drug users prescribed methadone in
2004 was 19227. It is thought that that ﬁgure has increased in the
period following this work and may now be closer to 22,224.6 Since
Scotland has an estimated total problem drug using population of
around 51,000,7 then on the basis that it is unlikely that more than
half of the total addict population are in treatment, it would appear
that virtually all problem drug users in Scotland in treatment are
indeed being prescribed methadone. By contrast, Scotland has only
minimal provision of residential rehabilitation services. It is these
latter services that our wider research has shown to be much more
closely associated with drug users becoming drug free.8 It has been
frequently stated in Scotland, and reiterated in the newdrug strategy,
that no one treatment suits all addicts. In reality, the situationwe face
within Scotland is precisely the opposite of that statement in which
thevastmajorityofdrugusers seeking treatmentare indeedprovided
with methadone. Commenting on that state of affairs in no way
conﬂicts with the contents of our paper but is entirely congruent
with our call for a mixed economy of drug treatment services.
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doi:10.1016/j.puhe.2009.02.009Multiparous women: A key target
population for smoking intervention?Schneider et al.1 used data from the German national registry to
identify risk factors for smoking during pregnancy. They concluded
that target groups for smoking cessation intervention include
women who are young (<20 years of age), single, of low socio-
economic status and, remarkably, who have had two or more
pregnancies.
We were particularly interested in the latter association, since
smoking has been associatedwith decreased fertility2 and, interest-
ingly, increased prevalence of twin pregnancies.3 This last associa-
tion may result from the effects of nicotine administration on
hormonal pathways, thereby increasing the likelihood of a twin
pregnancy; alternatively, women who have a genetic predisposi-
tion to have twins may be protected against the detrimental effects
of smoking.
A recent study found that dizygotic (DZ) twinning is associated
with smoking prior to the twin pregnancy.4 Prompted by Schneider
et al.’s paper, we returned to the original survey data collected from
mothers of twins registered with the Netherlands Twin Register
(n¼ 19,357), and looked at the distribution of smoking during preg-
nancy as a function of mode of conception (spontaneous versus
fertility treatment). As shown in Table 1, 15.9% of the mothers
with spontaneous twin pregnancies smoked during pregnancy,
while this was much lower (10.6%) in mothers who had fertility
treatment.
With regards to the ﬁndings by Schneider et al., these data
suggest at least one mechanism for the association between
smoking and parity; the nulliparous group is more likely to include
women who had their children following in-vitro fertilization or
other fertility treatment, during which they will be strongly
advised to quit smoking. In addition, given our results and the
fact that increased parity is also related to a higher chance of giving
birth to DZ twins, it is possible that part of the association between
smoking during pregnancy and parity is due to the presence of DZ
twin pregnancies in the population.
We do not know whether this information is available for the
German national registry, but it would be of interest to see whether
the association with parity remains after removing twin pregnan-
cies (especially DZ) and pregnancies after fertility treatment from
the analysis.a
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